Ignite Creation Date:
2024-05-05 @ 4:49 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00327691
Status:
COMPLETED
Last Update Posted:
2007-05-03
First Post:
2006-05-16
Brief Title:
A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
The Effect Of LDL-Cholesterol Lowering Beyond Currently Recommended Minimum Targets On Coronary Heart Disesse CHD Recurrence In Patients With Pre-Existing CHD
Status:
COMPLETED
Status Verified Date:
2007-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TNT
Brief Summary:
The primary objective of this study is to determine the degree of additional reduction in cardiovascular risk that was accrued to patients by lowering their LDL-C beyond the currently accepted minimum target level for patients with pre-existing CHD Secondary objectives include the safety profile of this treatment strategy its cost-effectiveness effect on other atherosclerotic-related events and procedures and total mortality
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| A2581136 | None | None | None |